Patents Assigned to The University of Guelph
-
Publication number: 20220272885Abstract: ‘V84031’ is a self-fruitful sweet cherry tree distinguished by its early flowering and large mahogany-colored fruit.Type: ApplicationFiled: February 24, 2021Publication date: August 25, 2022Applicant: The University of GuelphInventors: Jayasankar Subramanian, Bill Lay, Ghassem Tehrani
-
Patent number: 10842858Abstract: Vaccines comprising TRAP polypeptides and Salmonella enteritidis vectors comprising TRAP polypeptides are provided. The vaccines may also include a CD154 polypeptide capable of binding to CD40. Also provided are methods of enhancing an immune response against Apicomplexan parasites and methods of reducing morbidity associated with infection with Apicomplexan parasites.Type: GrantFiled: July 6, 2018Date of Patent: November 24, 2020Assignees: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, THE TEXAS A&M UNIVERSITY SYSTEM, THE UNIVERSITY OF GUELPHInventors: Walter Bottje, Billy Hargis, Luc Berghman, Young Min Kwon, Kimberly Cole, Mandy Cox, Sherryll Layton, Saeed El-Ashram, John Barta, Guillermo Tellez
-
Publication number: 20150216954Abstract: Vaccines comprising TRAP polypeptides and Salmonella enteritidis vectors comprising TRAP polypeptides are provided. The vaccines may also include a CD 154polypeptide capable of binding to CD40. Also provided are methods of enhancing an immune response against Apicomplexan parasites and methods of reducing morbidity associated with infection with Apicomplexan parasites.Type: ApplicationFiled: February 16, 2015Publication date: August 6, 2015Applicants: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS, THE TEXAS A&M UNIVERSITY SYSTEM, THE UNIVERSITY OF GUELPHInventors: Walter Bottje, Billy Hargis, Luc Berghman, Young Min Kwon, Kimberly Cole, Mandy Cox, Sherryll Layton, Said El-Ashram, John Barta, Guillermo Tellez
-
Patent number: 8956849Abstract: Vaccines comprising TRAP polypeptides and Salmonella enteritidis vectors comprising TRAP polypeptides are provided. The vaccines may also include a CD154 polypeptide capable of binding to CD40. Also provided are methods of enhancing an immune response against Apicomplexan parasites and methods of reducing morbidity associated with infection with Apicomplexan parasites.Type: GrantFiled: November 3, 2008Date of Patent: February 17, 2015Assignees: The Board of Trustees of the University of Arkansas, The Texas A&M University System, The University of GuelphInventors: Walter Bottje, Billy Hargis, Luc Berghman, Young Min Kwon, Kimberly Cole, Mandy Cox, Sherryll Layton, Said El-Ashram, John Barta, Guillermo Tellez
-
Publication number: 20140173779Abstract: The invention provides nucleotide sequences that can be used in operable association with a promoter to express a polynucleotide sequence of interest in a plant, plant part or plant cell at particular stages of development and/or in specific tissues. and methods for directing developmental stage specific and/or tissue specific expression of a polynucleotide of interest.Type: ApplicationFiled: April 5, 2013Publication date: June 19, 2014Applicants: The University of Guelph, Syngenta Participations AGInventors: Christophe Liseron-Monfils, Manish N. Raizada, Joseph Colasanti, Gregory Downs, Yong-Mei Bi, Lewis N. Lukens, Steven J. Rothstein, Tong Zhu, Xi Chen
-
Patent number: 8586825Abstract: The present invention relates to a nitrogen-regulated GATA transcription factor gene required for sugar sensing and the modulation of the expression of this gene to modulate a characteristic in a plant. The GATA transcription factor of the present invention is involved in regulating sugar sensing in plants and its expression is influenced by nitrogen status. Increased expression of this or substantially similar genes can produce plants with improved nitrogen utilization and increased yield.Type: GrantFiled: June 29, 2009Date of Patent: November 19, 2013Assignee: The University of GuelphInventors: Steven Rothstein, Yong-Mei Bi
-
Patent number: 8501190Abstract: There is provided a vaccine for controlling Clostridium perfringens in animals, and particularly necrotic enteritis in poultry. The vaccine may comprise a C. perfringens antigenic polypeptide or variant thereof, a nucleic acid encoding the C. perfringens antigenic polypeptide or variant thereof, or a recombinant cell producing the C. perfringens antigenic polypeptide or variant thereof.Type: GrantFiled: May 30, 2008Date of Patent: August 6, 2013Assignee: The University of GuelphInventors: John Prescott, Raveendra Kulkarni, Valeria Parreira, Shayan Sharif
-
Publication number: 20070076890Abstract: Flattening total current consumption of system having processing core and power supply input by current sensing within system at power supply input and controlling system current consumption such that system current is reduced if over reference current threshold, and increased if below reference current threshold. Inject additional current through digital injections cells working higher frequencies, by increasing switching activity, by increasing voltage supply to core, and by increasing operating frequency of processor core. Feedback signal indicates current consumption of system. Current consumption similarly decreased. Current sensed by mirroring input current inline with power supply input and compensating for voltage drop introduced by mirroring using opposing field effect transistors and maintaining outputs at same voltage through feedback control loop. Processor core may be general purpose processor core or cryptographic processor core. System may be system-on-chip or system-on-package.Type: ApplicationFiled: August 24, 2006Publication date: April 5, 2007Applicant: The University of GuelphInventors: Radu Muresan, Stefano Gregori
-
Patent number: 5378615Abstract: A serum-free vaccine effective against pneumonic pasteurellosis in cattle comprising a non-toxic leukotoxin specific for ruminant leukocytes is disclosed. The leukotoxin is prepared in a serum-free medium from a culture of Pasteurella haemolytica. The produced leukotoxin is harvested from the culture medium upon detecting a certain stage during the logarithmic phase of the cell growth to obtain the optimum concentration of produced cytotoxin in the serum-free medium. Cattle may be treated with the vaccine to develop anti-leukotoxic immunity to pneumonic pasterellosis.Type: GrantFiled: October 9, 1992Date of Patent: January 3, 1995Assignee: The University of GuelphInventors: Patricia E. Shewen, Bruce N. Wilkie
-
Patent number: 5215773Abstract: A method is provided for selecting starch-containing vegetables which are subject to low temperature sweetening based on the quality of product to be derived from said vegetables when processed in a manner which can result in undesirable product coloration due to chemical changes of surface sugars on the prepared product, a predetermined minimum level of starch granule crystallinity being established for the vegetable to be processed, above which minimal level an acceptable quality of processed product having an acceptable level of coloration is assured. The method comprises measuring starch granule crystallinity of the vegetable to be processed and selecting for later processing vegetables having a measured starch granule crystallinity above a predetermined minimum level which indicates that the vegetable will resist low temperature sweetening.Type: GrantFiled: September 25, 1990Date of Patent: June 1, 1993Assignee: The University of GuelphInventors: Rickey Y. Yada, Valerie Smith, David Stanley, Robert H. Coffin, Michael J. Leszkowiat
-
Patent number: PP34466Abstract: ‘V84031’ is a self-fruitful sweet cherry tree distinguished by its early flowering and large mahogany-colored fruit.Type: GrantFiled: February 24, 2021Date of Patent: August 2, 2022Assignee: The University of GuelphInventors: Jayasankar Subramanian, Bill Lay, Ghassem Tehrani